CARRIE LYNN: Open Payments
NPI 1912035064 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 65 payments from 14 companies in 2025. Trend: 2023 $1,745 · 2024 $1,718 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $675 |
| E.R. Squibb & Sons, L.L.C. | 28 | $226 |
| SCPHARMACEUTICALS INC. | 7 | $211 |
| PFIZER INC. | 9 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $143 |
| Kestra Medical Technology Services, Inc. | 1 | $48 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
Products named: Rapiblyk, FUROSCIX, CAMZYOS, JARDIANCE, VYNDAQEL, ELIQUIS, Assure WCD, NEXLETOL.
Industry payments across MD — which companies pay providers there.
